Randomized, controlled phase II trial of exemestane compared with medroxyprogesterone after nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer.
T. Wang
No relevant relationships to disclose
H. Huang
No relevant relationships to disclose
S. Zhang
No relevant relationships to disclose
L. Bian
No relevant relationships to disclose
Z. Jiang
No relevant relationships to disclose